Floxin and Coronary artery disease aggravated - a phase IV clinical study of FDA data

Summary:

Coronary artery disease aggravated is reported as a side effect among people who take Floxin (ofloxacin), especially for people who are male, 60+ old, also take Coumadin, and have Atrial fibrillation/flutter.

The phase IV clinical study analyzes which people have Coronary artery disease aggravated when taking Floxin. It is created by eHealthMe based on reports of 1,723 people who have side effects when taking Floxin from the FDA, and is updated regularly.

What is Floxin?

Floxin has active ingredients of ofloxacin. eHealthMe is studying from 1,737 Floxin users. Check the latest studies of Floxin.

What is Coronary artery disease aggravated?

Coronary artery disease aggravated (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart) is found to be associated with 1,237 drugs and 495 conditions by eHealthMe. Check the latest studies of Coronary artery disease aggravated.

On Jul, 19, 2026

1,723 people reported to have side effects when taking Floxin.
Among them, 15 people (0.87%) have Coronary artery disease aggravated.

Could Floxin cause Coronary artery disease aggravated?

Among these 15 people:

What is the gender of people who have Coronary artery disease aggravated when taking Floxin? *

female: 46.67 %
male: 53.33 %

What is the age of people who have Coronary artery disease aggravated when taking Floxin? *

What are other drugs people take besides Floxin? *

What are other side effects people have besides Coronary artery disease aggravated? *

Pain: 9 people, 60.00%
Cardiac Failure Congestive: 8 people, 53.33%
Angina Unstable (chest pain due to ischemia of the heart muscle- unstable): 7 people, 46.67%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 7 people, 46.67%
Chest Pain: 7 people, 46.67%
Heart Attack: 6 people, 40.00%
Mental Status Changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation): 6 people, 40.00%
Emotional Disorder: 6 people, 40.00%
Pneumonia: 6 people, 40.00%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 6 people, 40.00%

What are the existing conditions these people have? *

Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 5 people, 33.33%
Pain: 1 person, 6.67%
Kidney Stones: 1 person, 6.67%
Joint Pain: 1 person, 6.67%
Insomnia (sleeplessness): 1 person, 6.67%
Cardiac Failure Congestive: 1 person, 6.67%
Bladder Cancer: 1 person, 6.67%
Back Pain: 1 person, 6.67%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 1 person, 6.67%
Allergic Rhinitis: 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Floxin and have Coronary artery disease aggravated?

- Check whether Coronary artery disease aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Floxin:

Floxin (1,737 reports)

Browse all side effects of Floxin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Coronary artery disease aggravated:

Coronary artery disease aggravated (1,237 drugs)

Browse all the conditions that are associated with Coronary artery disease aggravated:

Coronary artery disease aggravated (495 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ofloxacin (the active ingredients of Floxin) and Floxin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.